Companies · Other Health Care

Emerald TopCo, Inc.

NEW YORK · Other Health Care · https://www.topco.com/contact

Diligence memoA one-page analyst read on Emerald TopCo, Inc. — recommendation, valuation, rhythm, risks.
$1.3B
Total raised · real
2
Rounds
0.0×
Latest step-up
Top 1%
Sector rank · raised
Growth/Late
Latest stage · inferred · Mon Dec 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time)

Emerald TopCo, Inc. has raised $1.3B over 2 rounds; too few niche peers to rank its valuation yet.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Dormant
  • Last raise 9.5 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Emerald TopCo, Inc. is one of 5376 Other Health Care companies tracked from NEW YORK. By capital raised it ranks among the largest (ahead of 100% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

AI analyst read est. — model-extracted from this company's public description, not a verified fact. 30%

operates a technology-led product inferred from public copy

Grounded in: “You are a venture analyst

Topco > Contact

Please direct media requests to Phil Barnes, Corporate Communications Manager pbarnes@topco.com To view Topco's latest news, click here . The Itasca office (Headquarters) is the home of the following programs: Grocery, Frozen, Dairy, General Merchandise, Health & Beauty Care, Pharmacy, Produce & Floral, Deli-Bakery-Foodservice, and Meat & Seafood.

Find Topco > Contact online

Trades publicly as Topco > Contact.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
3
Investors (latest)
2016
Year incorporated
2016-12-19
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$12.5B$25.0B$37.5B$50.0BGrowth/Late · 2016-10-21 Raised $1.3B (real) Modeled valuation $31.7B (est)$1.3B$31.7BGrowth/Late2016Growth/Late · 2016-12-19 Raised $1.6M (real) Modeled valuation $37M (est)$1.6M$37MGrowth/Late2016+$1.6MCumulative $1.3B

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Growth/Late$1.3B · 2016
Growth/Late extension$1.6M · 2016

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series A, Series B, Series C, Series D+ — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 14%.

Modeled valuation trajectory
$36.7M
Base estimate est.
$11.4M
Conservative case
$66.1M
Upside case
$15.5M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Growth/Latea round over $400M). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Growth/Late · modeled $31.7B · 2016-10-212016Growth/Late · modeled $36.7M · 2016-12-192016
Model inputs · modeled:benchmark-stage-stepup-v1
10%
Dilution assumption
Implied ownership sold in the financing.
85%
Survival probability
73% low · 91% high
1.19×/yr
Annual markup
1.29×/yr upside case
6.0 yr
Elapsed time used
9.5 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
2 mo
Avg between rounds
Capital velocity
9.7 yr
On record since
2016
First round
2
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 552× above median
This company$1.3B
Sector median$2.4M
Latest round — vs other Growth/Late rounds in sector (real $, this stage) 0.0× of median
This company$1.6M
Sector median$475.0M
Modeled value — vs sector median (estimate, all stages) 1.7× above median
This company$36.7M
Sector median$22.1M

Raised more than 100% of sector peers (real $). Modeled value above 62% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Growth/Late) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful.

This companyCohort peer
$10.0M$100.0M$1.0B$10.0B$100.0B$100.0M$1.0B$10.0BCapital raised (log)Bella Holding Company, LLC · Growth/Late Raised $690.6M · modeled $16.4B (est)EQT Avatar Parent L.P. · Growth/Late Raised $505.9M · modeled $12.0B (est)SM Midco L.P. · Growth/Late Raised $406.8M · modeled $9.6B (est)Emerald TopCo, Inc. (this company) Raised $1.3B · modeled $36.7M (est)Emerald TopCo, Inc.
CompanyStageRaised · realValue · estvs peer med.
Bella Holding Company, LLCGrowth/Late$690.6M$16.4B1.51×
EQT Avatar Parent L.P.Growth/Late$505.9M$12.0B1.11×
SM Midco L.P.Growth/Late$406.8M$9.6B0.89×
Emerald TopCo, Inc. this companyGrowth/Late$1.3B$36.7M0.00×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Growth/Late$1.3B2016-10-21$13.4B$31.7B90%
Growth/Late$1.6M2016-12-19$15.5M$36.7M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Growth/Late$1.3B2016-10-21
    • First recorded raise — entered as Growth/Late.
    • 32 investors on this round.
  2. Growth/Late$1.6M2016-12-19
    • Came back fast: 2 mo vs the ~14 mo sector norm.
    • Round 864.0× smaller than the prior — bridge or down round.
    • 3 investors on this round.
Intelligence
2017 ~Q1
Modeled next raise · ~2mo cadence
$1.6M
Modeled next size est.range $1.6M$2.5M
0.0×
Last step-up
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Eric Liu4 other2016-10
Jason Howard4 other2016-10
Robert Bradburn2 other2016-10
Ethan Waxman1 other2016-10
Jonathan Brook1 other2016-10
Julie Gilbert1 other2016-10
Patrick T. Ryan1 other2016-12
Bernhard T. Hampl2016-12
Harry T. Klagsbrun2016-12
Mark T. Tabak2016-12
Registry & provenance

Emerald TopCo, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1688674
SEC CIK
2016
Incorporated
Recent activityActive

Discovered from topco — the partnerships, launches, hiring and press it publishes about itself. Evidence the company is alive and what it is doing now, not financial data.

Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
EQT Avatar Parent L.P.Other Health CareGrowth/Late$505.9M$12.0Bnetwork5 shared operators · same sector · same stage
WP Rocket Holdings Inc.Other Health CareSeries B$28.8M$73.9Mnetwork1 shared operator · same sector
Regional Diagnostic Laboratories, Inc.Other Health CareSeries A$9.1M$91.6Mnetwork1 shared operator · same sector
EQT Private Equity Co LLCOtherGrowth/Late$468.6M$4.7Bnetwork1 shared operator · same stage
Sonendo, Inc.Other Health CareSeries C$241.5M$33.0Msame sector
Centinel Spine, LLCOther Health CareSeries D+$181.2M$34.3Msame sector
Metabolon, IncOther Health CareSeries B$123.6M$42.1Msame sector
ArcherDX, Inc.Other Health CareSeries C$115.1M$35.6Msame sector
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Bellevue Topco, Inc.
Topco > Contact
OtherGrowth/Late$25.3B95%
Papay Topco, Inc.
Topco > Contact
OtherGrowth/Late$26.6B95%
Torreys Topco, Inc.
Topco > Contact
OtherGrowth/Late$16.0B95%
Globetrotter Topco, Inc.
Topco > Contact
Other TechnologyGrowth/Late$28.6B94%
Tallinn Topco, Inc.
Topco > Contact
OtherGrowth/Late$20.7B94%
Gainster Topco, Inc.
Topco > Contact
OtherGrowth/Late$15.7B94%
Office Topco, LlcOtherSeries D+$4.1B78%
Merritt Topco, Inc.
Topco > Who We Are > Programs
OtherGrowth/Late$20.7M77%
Frequently asked
How much funding has Emerald TopCo, Inc. raised?
Emerald TopCo, Inc. has raised approximately $1.3B in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is Emerald TopCo, Inc.'s estimated valuation?
Provath's modeled valuation for Emerald TopCo, Inc. is approximately $36.7M (modeled range $11.4M–$66.1M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Emerald TopCo, Inc. at?
Emerald TopCo, Inc.'s latest modeled financing stage is Growth/Late. Its most recent recorded round closed around Mon Dec 19.
What does Emerald TopCo, Inc. do and where is it based?
Emerald TopCo, Inc. operates in the Other Health Care sector, based in NEW YORK. Topco > Contact
Explore related

See where Emerald TopCo, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Emerald TopCo, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.